Evidence map›Paper›PMID 36270327›Full record

ArticleDevelopmental biology2022

TurboID functions as an efficient biotin ligase for BioID applications in Xenopus embryos.

Charlotte R Kanzler, Michael Donohue, Megan E Dowdle, Michael D Sheets

Open access · hybridAbstract read
In one paragraph

Article in Developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Cancers · 2025
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Charlotte R KanzlerDepartment of Biomolecular Chemistry, School of Medicine and Public Health, University of, Wisconsin, Madison, United States; Cell and Molecular Biology Program, United States.
Michael DonohueDepartment of Biomolecular Chemistry, School of Medicine and Public Health, University of, Wisconsin, Madison, United States.
Megan E DowdleDepartment of Biomolecular Chemistry, School of Medicine and Public Health, University of, Wisconsin, Madison, United States.
Michael D SheetsDepartment of Biomolecular Chemistry, School of Medicine and Public Health, University of, Wisconsin, Madison, United States. Electronic address: mdsheets@wisc.edu.
University of Wisconsin–Madison · US

Funding

BIOTECHNOLOGY TRAINING PROGRAMT32GM008349 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI FOX, BRIAN G · 1989 to 2019
$22.5M
Biotechnology Training ProgramT32GM135066 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI SCOTT M. COYLE, BRIAN G FOX · 2020 to 2026
$7.0M
Regulation of cell fates by the Bicaudal-C translational repressorR01HD091921 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI SHEETS, MICHAEL D · 2018 to 2022
$1.5M
NICHD NIH HHS R01 HD091921NIGMS NIH HHS T32 GM008349NIGMS NIH HHS T32 GM135066
6 · The paper itself

Abstract

BioID is a proximity labeling strategy whose goal is to identify in vivo protein-protein interactions. The central components of this strategy are modified biotin ligase enzymes that promiscuously add biotin groups to proteins in close proximity. The transferred biotin group provides a powerful tag for purification and thus identification of interacting proteins. While a variety of modified biotin ligases were created for BioID, the original enzymes were inefficient, required long incubation times, and high intracellular biotin concentrations for protein labeling. These limitations hinder the application of BioID in contexts such as developing embryos where processes such as cell division and cell fate decisions occur rapidly. Recently, a new biotin ligase called TurboID was developed that addressed many of the deficiencies of previous enzymes. In this paper we compare TurboID to the BioID2 biotin ligase in developing Xenopus embryos. We find that the TurboID enzyme has several advantages over the BioID2 enzyme. TurboID labels proteins efficiently without the addition of additional biotin and occurs at a range of temperatures compatible with the culturing of Xenopus embryos. Biotinylation events occurred rapidly and were limited by TurboID expression and not its activity. Thus, TurboID is an efficient tool for BioID applications in Xenopus embryos and its use should facilitate the identification of interacting proteins in specific networks and complexes during Xenopus development.

Indexed as

BiotinLigasesAnimalsBiotinylationXenopus laevisBiotinLigasesBioID2BiotinylationTurboIDXenopus embryos

Identifiers

PMID36270327
PMCPMC9643680
OpenAlexW4306742827

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.